Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

There is little scientific data concerning the use of negative pressure therapy after immediate breast reconstruction. That strategy of treatment-reconstruction has expanded increasingly since the last years. The current literature reports only 3 studies on the use of preventive negative pressure therapy in oncologic breast surgery. Moreover, all three are retrospective, case-control studies with serious limitations. The largest published series reports a reduction in the overall complication rate from 15.9% to 8.5%, and a significant reduction in several criteria: infection, scar dehiscence and necrosis. However, the study presents significant biases, with non-comparable populations in terms of comorbidities, surgical procedure performed, inclusion periods (and therefore experience in performing oncological surgery). There was also a high probability of under-assessment or postponement of post-operative complications, which is typical of published retrospective surgical studies. The published results therefore strongly encourage further investigation of negative pressure therapy in oncological breast surgery.

Key facts

Study ID

NCT06265558

Run by

Institut du Cancer de Montpellier - Val d'Aurelle

People needed

254

Starts

2025-04-15

Expected to finish

2027-07-01

Last updated by the study team

2026-02-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female ≥ 18 years
• Patient with unilateral invasive or in situ breast carcinoma
• Patient with or without neoadjuvant treatment
• Patient presenting an indication for complex breast surgery by mastectomy with immediate breast reconstruction by implant or oncoplasty by T-shaped mammoplasty.
• Patient presenting at least one of the following risk factors for scarring disorders:
• Obesity with Body Mass Index BMI ≥ 30 and/or Cup size ≥ E
• Active smoking or smoking cessation for less than one month
• Diabetes
• History of homolateral breast radiotherapy
• Long-term corticosteroid therapy
• Patient to have signed informed consent prior to study entry
• Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures.
• Patient affiliated with a health insurance plan.

You may not qualify if…

• Legal incapacity or limited legal capacity. Medical or psychological conditions preventing the patient from completing the study or signing the consent form.
• Pregnant or breast-feeding patient as determined in medical records as part of standard patients care and follow-up
• Patient under guardianship or safeguard of justice
• Patient participating in an interventional study with the objective of wound healing
• Any concurrent or planned surgical procedure on the contralateral breast

Where it is running

• Centre Hospitalier de Montpellier — Montpellier, Hérault, France (enrolling)
• Centre Hospitalier de Nîmes — Nîmes, GARD, France (enrolling)
• Institut régional du Cancer de Montpellier — Montpellier, Hérault, France (enrolling)
• Institut de Cancérologie de l'Ouest — Angers, Maine Et Loire, France (enrolling)
• Centre Léon Bérard — Lyon, Rhône, France
• Institut Bergonié — Bordeaux, Gironde, France
• Centre Georges-François Leclerc — Dijon, Côte d'Or, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.